The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo
Open accessAbstract
Modulation of Tie2 receptor activity by its angiopoietin ligands is crucial for angiogenesis, blood vessel maturation, and vascular endothelium integrity. It has been proposed that angiopoietins 1 (Ang1) and 2 (Ang2) are pro- and anti-angiogenic owing to their respective agonist and antagonist signaling action through the Tie2 receptor. The function of Ang2 has remained controversial, however, with recent reports suggesting that in some circumstances, it may be pro-angiogenic. We have examined this issue using the transient ocular microvessel network called the pupillary membrane as a unique in vivo model for studying the effects of vascular regulators. We show that in vivo , in the presence of endogenous vascular endothelial growth factor (VEGF)-A, Ang2 promotes a rapid increase in capillary diameter, remodeling of the basal lamina, proliferation and migration of endothelial cells, and stimulates sprouting of new blood vessels. By contrast, Ang2 promotes endothelial cell death and vessel regression if the activity of endogenous VEGF is inhibited. These observations support a model for regulation of vascularity where VEGF can convert the consequence of Ang2 stimulation from anti- to pro-angiogenic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in the presence of VEGF, Ang-2 can prime vessels to mount a robust pro-angiogenic response (89)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S. H., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,872
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. T., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,350
Carmeliet, P., Lampugnani, M. G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oosthuyse, B., Dewerchin, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81010-7 · Cited by 1,284
Blood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,214
Role of vascular endothelial growth factor in regulation of physiological angiogenesis
Ferrara, N. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1358 · Cited by 1,094
Gerber, H., Dixit, V. M., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13313 · Cited by 991
Increased Vascularization in Mice Overexpressing Angiopoietin-1
Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H., Sato, T. N., & Yancopoulos, G. D. (1998) · Science · doi:10.1126/science.282.5388.468 · Cited by 818
Research works printed but not linked: 2
- Eggert A., Ikegaki, N., Kwiatkowski, J., Zhao, H., Brodeur, G. M. & Himelstein, B. P. (2000) Clin. Cancer Res.6,1900-1908.10815914
- Etoh T., Inoue, H., Tanaka, S., Barnard, G. F., Kitano, S. & Mori, M. (2001) Cancer Res.61,2145-2153.11280779
Cited by
Sorted by citations
Items 601–675 of 675
Sterzyńska, K., Sujka‐Kordowska, P., & Witkiewicz, W. (2011) · Postepy Biologii Komorki · doi:10.2478/v10052-011-0004-3 · Cited by 1
“On the other hand, induction of Ang2 in the absence of VEGF causes apoptosis of endothelial cells and correlates with vascular regression [43].”
BackgroundCirculating Levels of Adipokines Predict the Occurrence of Acute Graft-versus-host Disease
Kim, J. S., You, D.-B., Lim, J., et al. (2015) · Immune Network · doi:10.4110/in.2015.15.2.66 · Cited by 1
“liferation and migration of endothelial cells, and stimulates sprouting of new blood vessels (17).”
BackgroundPrognostic implication of expression of Angiopoietin-2 in acute myeloid leukemia
Fiedler, W., Schuch, G., & Loges, S. (2008) · Leukemia Research · doi:10.1016/j.leukres.2007.10.014 · Cited by 1
Chen, B., & Li, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809479-2.00010-x · Cited by 1
McDonnell, K., & Wellstein, A. (2007) · Springer eBooks · doi:10.1007/0-387-31056-8_19 · Cited by 1
Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy
Liu, M., Zhang, J., & Zhu, J. (2023) · Pharmaceutical Fronts · doi:10.1055/s-0043-1777704 · Cited by 1
“151 Bevacizumab treatment reduces IL-10-expressing circulating macrophage, 152 which could be a result of Ang2-VEGF blockade.”
BackgroundMolecular Biology of Human Brain Tumors
Coluccia, D., Weeks, A., Fandino, J., Schneider, C., Smith, C. A., & Rutka, J. T. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_35 · Cited by 1
Ahmadian, M., Azizbeigi, K., Delfan, M., & Atashak, S. (2019) · Medical Journal of Tabriz University of Medical Sciences and Health Services · doi:10.34172/mj.2019.001 · Cited by 1
Emerging Therapeutic Modalities for Diabetic Retinopathy
Uddin, M. I., & Jayagopal, A. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2020_101 · Cited by 1
Raga, D. D., Herrera, A. A., Shen, C. C., et al. (2015) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-015-1216-x · Cited by 1
Arterial Stiffness in Type 2 Diabetes Patients in Ghana
Yeboah, K. (2013) · Cited by 1
Mooney, D. J., & Yung, Y. C. (2006) · The electrical engineering handbook/Electrical engineering handbook series/Electrical engineering handbook · doi:10.1201/9781420003871.ch53 · Cited by 1
Gião, T., Saavedra, J., Vieira, J. R., Pinto, M. T., Arsequell, G., & Cardoso, I. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.16.440131 · Cited by 1
RANDI, A. M., & Castaman, G. (2024) · doi:10.1002/9781119419525.ch25 · Cited by 1
Constantinescu‐Bercu, A., Smith, K. E., Wong, S. Y., Ballerini, M., Nastro, A., Wiggins, B. G., Pirri, D., Li, A. K. C., Evers, J., Tsiamita, O., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.09.675051 · Cited by 1
Paavonen, K. (2003) · Työväentutkimus Vuosikirja · Cited by 1
VASCULAR GROWTH FACTORS AND PROGENITOR CELLS IN CARDIAC ALLOGRAFT ARTERIOSCLEROSIS
Nykänen, A. I. (2007) · Työväentutkimus Vuosikirja
Current Advances in Cerebral Malaria Associated Encephalopathy
Liu, M., Guo, S., Battle, M., & Jonathan, K. (2012) · InTech eBooks · doi:10.5772/30739
FACTORS ANGIOGÈNICS EN LA RETINOPATIA DIABÈTICA PROLIFERATIVA
García‐Ramírez, M., Hernández, C., Carrasco, E., et al. (2007) · Treballs de la Societat Catalana de Biologia
Abajo, A. (2014) · Deposito Adademico Digital Universidad De Navarra (University of Navarra)
Angiopoietin-1 and -2 in Infectious Diseases associated with Endothelial Cell Dysfunction
Page, A. V., & Liles, W. C. (2012) · TSpace (University of Toronto)
ROLE OF THE ANG-TIE2 PATHWAY IN THE INVASIVE RECURRENCE OF GBM FOLLOWING ANTI-VEGF THERAPY
Cortes‐Santiago, N. (2014) · Digital Commons-TMC (Texas Medical Center)
Satellite Symposia and Meet-the-Professor Sessions
Schmid, C., Schleuning, M., & Kolb, H.-J. (2006) · Annals of Hematology · doi:10.1007/s00277-005-0079-8
In vitro Thermoreversible Gel Disc Quantitative Assay of Rat Angiogenesis
Wakui, S., Muto, T., Anzai, N., et al. (2011) · doi:10.11232/aatex.16.59
Targeting Signal Transduction Pathways for the Treatment of Kaposi Sarcoma
Douglas, J. L., Koon, H. B., & Moses, A. V. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1513-9_5
“In the presence of high VEGF, Ang-2 antagonism of Tie-2 leads to vessel sprouting; but in the absence of VEGF, Ang-2 expression leads to vascular regression (Oh et al., 1999; Lobov et al., 2002).”
BackgroundGil, L. A., & Bellón, P. R. (2011) · Piel · doi:10.1016/j.piel.2010.12.016
Angiopoietins and Other Non-VEGF Antiangiogenic Targets in Advanced Renal Cell Carcinoma
Cowey, C. L., & Hutson, T. E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_7
Bajracharya, D. S. (2014) · Americanae (AECID Library)
Regulation of angiogenesis and vascular remodeling by angiogenic factors
Grass, T. M. (2004) · The Mathematics Enthusiast
The Role of Tie1 Threonine Phosphorylation in a Novel Angiogenesis Regulatory Pathway
Reinardy, J. L. (2015) · DukeSpace (Duke University)
C-Myc expression in adult and embryonic endothelial cells
Kókai, E. (2010) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-1876
Untersuchung zur transkriptionellen Regulation des Angiopoietin-2 in humanen Endothelzellen
Jonas, W. (2010) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/16180
“Bisher sind vor allem die angiogenen Wirkungen von VEGF-A und bFGF gut untersucht worden.”
BackgroundInfluentialAn investigation into the function and signalling of the endothelial receptor tyrosine kinase Tie 1
Salim, T. F. (2007) · Leicester Research Archive (University of Leicester)
Endothelial Biomarkers and the Pathogenesis of Cerebral Malaria
Tetteh, H. A. (2014)
The Role of Osteocyte Apoptosis on Osteoclast Precursor Recruitment
Cheung, W.-Y. (2013) · TSpace (University of Toronto)
[Research Advances of Ang-2 in Non-small Cell Lung Cancer].
Hua, X., & Zhu, X. (2018) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2018.11.09
Morbidelli, L., & Donnini, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90190-1.00018-4
Molecular Determinants of Embryonic Vascular Development
Baldwin, H. S., & Grindley, J. C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-3479-7.10064-3
Redondo, P., & Bastarrika, G. (2008) · Dermatologic Surgery · doi:10.1097/00042728-200812000-00019
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814072-7.09991-5
Mooney, D. J., & Yung, Y. C. (2007) · Tissue Engineering · doi:10.1201/9781420008333.ch24
(2007) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2007-37-6-652
Lasagni, S., Critelli, R. M., Milosa, F., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071424
“These changes result in a distinct shift in the hepatic microenvironment that ultimately promotes carcinogenesis [13,14,29].”
BackgroundHeng, J. S., & Sodhi, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13820-1.00108-0
Lin, M., Guo, J., Tang, W., Tao, H., Gu, Z., Zhou, F., Jiang, Y., Zhang, R., Jia, D., Sun, Y., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5112749
Cui, Y., Liu, H., Li, Z., et al. (2025) · Acta Astronautica · doi:10.1016/j.actaastro.2025.02.024
Kamao, H., Goto, K., Mizukawa, K., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186637
“Furthermore, Ang-2 promoted angiogenesis in the presence of VEGF and inhibited angiogenesis in the absence of VEGF [28].”
Smith, R. J. P., Faroni, A., Barrow, J. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14151205
Thompson, K. P., Sykes, J., Chandakkar, P., Marambaud, P., Vozoris, N. T., Marchuk, D. A., & Faughnan, M. E. (2022) · Figshare · doi:10.6084/m9.figshare.21520208
Spurrier-Best, L., Butcher, D. R., Blackham-Hayward, E., et al. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2025.1699112
“…the past, angiopoietin-2 has been shown to act as either a pro-or anti-angiogenic signal depending on the tissue and stimulus (Asahara et al., 1998; Lobov et al., 2002); however, it is now understood that in the presence of VEGF, angiopoietin-2 induces endothelial cell migration and sprouting to…”
CD146 + interstitial cells contribute to the dystrophic skeletal muscle phenotype in vitro
Mierzejewski, B., Michalska, Z., Kulma, D., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-38311-2
“However, Angpt-2 has proangiogenic properties only in the presence of Vegf, while in the absence of Vegf it inhibits tubulogenesis, promotes endothelial cell death, and vessel regression 63 .”
Robbins, J., Katz, D. H., Many, G. M., Rao, P., Smith, G. R., Tiwari, G., Jin, C. A., Spielmann, G., Montalvo, S., Iyer, G. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.02.704798 · Cited by 2
Kinase MSK1 et bronchiolite oblitérante
Nemska, S. (2012) · theses.fr (ABES) · doi:10.70675/291ee302z712fz4826za648z913b8044814d
Transdifférenciation radio-induite des cellules souches de glioblastome en cellules endothéliales
Deshors, P. (2019) · theses.fr (ABES) · doi:10.70675/143961e4z84c9z4ceaz9ec7z4312179bfb8f
Arab, O. A. (2020) · theses.fr (ABES) · doi:10.70675/d0d9e21cz6e67z4023z976fz59a00c372e01
Diversity of visual projections in vertebrates
Vigouroux, R. J. (2020) · theses.fr (ABES) · doi:10.70675/4e013149z524az4f80za5c1z99a2ca079cb0
Interactions vasculaires et hormonales dans l'hyperaldostéronisme primaire
Abdellatif, A. B. (2022) · theses.fr (ABES) · doi:10.70675/5f0b4f73zaca0z4bc4z99d5z8ca373f11d25
Neovascularization in rheumatoid arthritis pannus is orchestrated by endothelial-pericyte signalingPreprint
Miura, Y., Milad, N., Usami, A., Kosugi, S., Noguchi, H., & Kanazawa, S. (2026) · Research Square · doi:10.21203/rs.3.rs-9546936/v1
Jahromi, M., Al-Otaibi, T., Othman, N. F., Mahmoud, T. S. H., Nair, P., Halim, M. A., Jahrami, K., & Gheith, O. A. A. (2026) · Experimental and Clinical Transplantation · doi:10.6002/ect.mesot2025.p191
Faricimab in the Treatment of Retinal Disease: A Narrative Review
Zeaiter, M., Jaber, H., Gharbi, K., et al. (2026) · Cureus · doi:10.7759/cureus.114098
“Its expression is upregulated by the hypoxia-inducible factor 1, eventually leading to abnormal angiogenesis and alterations in the vasculature such as increased vascular permeability [15,16].”
Collado-Cuadrado, M., la Puente, A. B., Montero‐Calle, A., Vázquez-Ávila, S., Barderas, R., Sotillo, J., Carretón, E., Pericacho, M., & Morchón, R. (2026) · Parasites & Vectors · doi:10.1186/s13071-026-07307-2
“In the presence of VEGF-A, ANGPT2 is a potent pro-angiogenic factor that acts on basal lamina remodeling as well as endothelial cell proliferation and migration; however, in the absence of VEGF-A, the protein induces cell death and vascular regression [24, 25].”
Whitney, A. M. (2022) · UPT. Syiah Kuala University Library (Syiah Kuala University) · doi:10.57709/1392635
Metadata
- Authors
- Lobov, I. B., Brooks, P. C., & Lang, R. A.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Lang, Richard A.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-08-05
- Volume
- 99
- Issue
- 17
- Pages
- 11205-11210
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC123234
- OpenAlex
- W2113920157
- Semantic Scholar
- 60029f2ec9a0f8c30ad5b2536f206fc2cbab3666
- Cited by
- 676
- References
- 30
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 32 · 2023: 20 · 2022: 31 · 2021: 23 · 2020: 14 · 2019: 24 · 2018: 21 · 2017: 16 · 2016: 25 · 2015: 34 · 2014: 29 · 2013: 37 · 2012: 35
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- International Retinal Research Foundation
- National Institutes of Health (5r01ey012370-05)
- National Eye Institute (R01EY014102, R01 EY12370, R01EY011234, R01EY010559)
- National Cancer Institute (R01CA091645)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- angiopoietin-2, angiopoietin-1, Tie2 receptor, VEGF-A, angiogenesis, capillary structure, endothelial cell survival, endothelial cell death, vessel regression, endothelial cell proliferation, endothelial cell migration, capillary diameter, pupillary membrane, ocular microvasculature
- MeSH terms
- Animals, Capillaries, Cell Division, Cornea, Endothelium, Vascular, Enzyme Inhibitors, Humans, Lymphokines, Muscle, Smooth, Vascular, Proteins, Recombinant Proteins, Endothelial Growth Factors, Rats, Sprague-Dawley, Apoptosis, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Angiopoietin-2, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review